17-Hydroxyprogesterone, Serum
Bromazepam
Oxcarbazepine, Urine
Lung Cancer, ROS1 (6q22) Rearrangement, FISH, Tissue
Fatty Acid Profile, Serum
Phospholipase A2 Receptor (PLA2R), Immunofluorescent Stain, Renal
Arylsulfatase A, 24 Hour, Urine
HER2/neu (ERBB2), IHC, Semi-Quantitative, Other Tissue
Fatty Acid Profile, Peroxisomal
Enhancer of zeste homolog 2 (EZH2) Gene Mutation Analysis
LDS
Sign up
Log in
LDS
/
Medical Tests
/
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
Medical Test
Additional ICD10
Access to
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
is restricted.
Sign up now
Loading...